The stimulatory effect of the TLR4-mediated adjuvant glucopyranosyl lipid A is well preserved in old age
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Many subunit vaccines require adjuvants to improve their limited immunogenicity. Various adjuvant candidates targeting toll-like receptors (TLRs) are currently under development including the synthetic TLR4 agonist glucopyranosyl lipid A (GLA). GLA has been investigated in the context of influenza vaccine, which is of particular importance for the elderly population. This study investigates the effect of GLA on antigen-presenting cells from young (median age 29 years, range 26-33 years) and older (median age 72 years, range 61-78 years) adults. Treatment with GLA efficiently increases the expression of co-stimulatory molecules on human monocyte-derived dendritic cells (DC) as well as on ex vivo myeloid DC. Expression of co-stimulatory molecules is less pronounced on ex vivo monocytes. Production of pro-inflammatory cytokines (IL-6, TNF-α, IL-12) as well as of the anti-inflammatory cytokine IL-10 is induced in monocyte-derived DC. In PBMC cultures myeloid DC and to an even greater extent monocytes produce TNF-α and IL-6 after stimulation with GLA. Production of IL-12 can also be observed in these cultures. There are no age-related differences in the capacity of GLA to induce expression of co-stimulatory molecules or production of cytokines by human antigen-presenting cells. Therefore, TLR4 agonists like GLA are particularly promising candidates as adjuvants of vaccines designed for elderly individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it has been shown recently that there are no age-related differences in the capacity of the synthetic TLR4 agonist glucopyranosyl lipid A to induce expression of co-stimulatory molecules or production of cytokines by human antigen-presenting cells [51].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [51]
Citations
Cites
Towards an understanding of the adjuvant action of aluminium
Marrack, P., McKee, A. S., & Munks, M. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2510 · Cited by 887 · cited 2×
“Whereas subunit or protein vaccines adjuvanted with aluminum salts potently induce Th2-biased and antibody responses (Grun and Maurer 1989; Marrack et al. 2009), other adjuvants are needed to effectively stimulate Th1 and CD8?”
Clinical Relevance of Age-Related Immune Dysfunction
Castle, S. C. (2000) · Clinical Infectious Diseases · doi:10.1086/313947 · Cited by 640
Cutting edge: impaired toll-like receptor expression and function in aging
Renshaw, M., Rockwell, J., Engleman, C., Gewirtz, A., Katz, J., & Sambhara, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4697 · Cited by 626 · cited 5×
“mice were found to secrete significantly lower amounts of TNF-a and IL-6 upon stimulation with LPS and other TLR agonists in comparison to macrophages from young mice (Renshaw et al. 2002).”
InfluentialPanda, A., Qian, F., Mohanty, S., van Duin, D., Newman, F. K., Zhang, L., Chen, S., Towle, V., Belshe, R. B., Fikrig, E., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901022 · Cited by 548 · cited 8×
“In humans 10 TLRs have been described, which are localized at the cell membrane (TLR1, 2, 4, 5, 6, 10) or intracellularly (TLR3, 7, 8, 9).”
InfluentialRobbins, S. H., Walzer, T., Dembélé, D., Thibault, C., Defays, A., Bessou, G., Xu, H., Vivier, E., Sellars, M., Pierre, P., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-1-r17 · Cited by 533 · cited 2×
“, blood-derived versus moDC (Osugi et al. 2002; Radford et al. 2006; Robbins et al. 2008) and the mode of cell preparation (Jiang et al.”
Molecular and cellular signatures of human vaccine adjuvants
Mosca, F., Tritto, E., Muzzi, A., Monaci, E., Bagnoli, F., Iavarone, C., O'Hagan, D., Rappuoli, R., & De Gregorio, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804699105 · Cited by 492 · cited 3×
“The oil-in-water emulsion MF59, consisting of squalene, Tween80 and Span 85 (Ott et al. 1995) was licensed in 1997 for use with seasonal influenza vaccines in Europe.”
Lim, K.-H., & Staudt, L. M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011247 · Cited by 469
Accessory molecules for Toll-like receptors and their function
Lee, C. C., Avalos, A. M., & Ploegh, H. L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3151 · Cited by 439 · cited 1×
“TLRs recognize different ligands derived from bacteria, fungi, viruses or damaged host cells [reviewed in (Lee et al. 2012; Lim and Staudt 2013)].”
Agrawal, A., Agrawal, S., Cao, J.-N., Su, H., Osann, K., & Gupta, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6912 · Cited by 435 · cited 2×
“Expression of TLR4 was not assessed on moDC in the present study, but was reported to be unaltered on moDC from elderly persons (Agrawal et al. 2007).”
InfluentialInnate immunity in aging: impact on macrophage function
Plowden, J., Renshaw‐Hoelscher, M., Engleman, C., Katz, J., & Sambhara, S. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00102.x · Cited by 431 · cited 1×
“In mouse and man the activation of monocytes/macrophages as well as their capacity to present antigen and stimulate T cells seems to be impaired (McLachlan et al. 1995; Pawelec 1999; Castle 2000; Herrero et al. 2002; Plowden et al. 2004).”
Biology of Immune Responses to Vaccines in Elderly Persons
Weinberger, B., Herndler‐Brandstetter, D., Schwanninger, A., Weiskopf, D., & Grubeck‐Loebenstein, B. (2008) · Clinical Infectious Diseases · doi:10.1086/529197 · Cited by 392 · cited 1×
“With increasing age the innate and adaptive immune system undergoes characteristic changes, termed immunosenescence (Weinberger et al. 2008).”
Self-citationColer, R. N., Bertholet, S., Moutaftsi, M., Guderian, J. A., Windish, H. P., Baldwin, S. L., Laughlin, E. M., Duthie, M. S., Fox, C. B., Carter, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016333 · Cited by 312 · cited 10×
“The current study focused on the TLR4-mediated adjuvant candidate GLA, which has been shown to enhance the immunogenicity of co-administered antigens in mice and non-human primates (Coler et al. 2010, 2011; Arias et al. 2012) without causing adverse side effects (Coler et al. 2010).”
Self-citationMF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
Ott, G., Barchfeld, G. L., Chernoff, D., Radhakrishnan, R., van Hoogevest, P., & Van Nest, G. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_10 · Cited by 298 · cited 1×
“The oil-in-water emulsion MF59, consisting of squalene, Tween80 and Span 85 (Ott et al. 1995) was licensed in 1997 for use with seasonal influenza vaccines in Europe.”
Jing, Y., Shaheen, E., Drake, R. R., Chen, N., Gravenstein, S., & Deng, Y. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.07.005 · Cited by 284 · cited 2×
“Previous reports demonstrated intact TLR4 expression in old age on human conventional DC and murine splenic DC (Jing et al. 2009; Wong et al. 2010), whereas macrophages of elderly mice were found to express lower levels of TLR4 and other TLRs on their surfaces than young mice (Renshaw et al. 2002).”
Grun, J. L., & Maurer, P. H. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90011-7 · Cited by 281 · cited 2×
“Whereas subunit or protein vaccines adjuvanted with aluminum salts potently induce Th2-biased and antibody responses (Grun and Maurer 1989; Marrack et al. 2009), other adjuvants are needed to effectively stimulate Th1 and CD8?”
Taking toll: lipid A mimetics as adjuvants and immunomodulators
Persing, D. H., Coler, R. N., Lacy, M. J., Johnson, D. A., Baldridge, J. R., Hershberg, R. M., & Reed, S. G. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02426-5 · Cited by 258 · cited 1×
“MPL has been shown to successfully enhance murine and human T cell responses against viruses and bacteria (Masihi et al. 1986; Persing et al. 2002) and to induce predominantly Th1 responses (Alderson et al. 2006).”
Self-citationThe virosome concept for influenza vaccines
Huckriede, A., Bungener, L., Stegmann, T., Daemen, T., Medema, J., Palache, A. M., & Wilschut, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.026 · Cited by 250 · cited 2×
“2006), as well as virosomal formulations of antigens (Huckriede et al. 2005) have been introduced in combination with various antigens, such as seasonal and pandemic influenza, hepatitis A and B and human papilloma virus (HPV).”
Osugi, Y., Vuckovic, S., & Hart, D. N. J. (2002) · Blood · doi:10.1182/blood.v100.8.2858 · Cited by 216 · cited 2×
“, blood-derived versus moDC (Osugi et al. 2002; Radford et al. 2006; Robbins et al. 2008) and the mode of cell preparation (Jiang et al.”
Lung, T. L., Saurwein-Teissl, M., Parson, W., Schönitzer, D., & Grubeck-Loebenstein, B. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00494-6 · Cited by 161 · cited 3×
“of moDC from old donors to different stimuli (Saurwein-Teissl et al. 1998, 2000; Lung et al. 2000) and of murine conventional DC stimulated with LPS (Pereira et al.”
Self-citationvan Duin, D., Allore, H. G., Mohanty, S., Ginter, S., Newman, F. K., Belshe, R. B., Medzhitov, R., & Shaw, A. C. (2007) · The Journal of Infectious Diseases · doi:10.1086/516788 · Cited by 159 · cited 2×
“These findings strongly argue against a decreased responsiveness to TLR4-agonists with age in contrast to impaired responses to agonists of other TLRs (van Duin et al. 2007; Panda et al. 2010).”
Immunosenescence of macrophages: reduced MHC class II gene expression
Herrero, C., Sebastián, C., Marqués, L., Comalada, M., Xaus, J., Valledor, A. F., Lloberas, J., & Celada, A. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00205-4 · Cited by 156 · cited 1×
“In mouse and man the activation of monocytes/macrophages as well as their capacity to present antigen and stimulate T cells seems to be impaired (McLachlan et al. 1995; Pawelec 1999; Castle 2000; Herrero et al. 2002; Plowden et al. 2004).”
Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
Thoelen, S., Damme, P. V., Matheï, C., Leroux-Roels, G. G., Desombere, I., Safary, A., Vandepapelière, P., Slaoui, M., & Meheus, A. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00254-5 · Cited by 156 · cited 2×
“other adjuvants such as AS03 (oil-in water emulsion containing squalene, Tween80 and a-tocopherol) (Walker and Faust 2010), AS04 (aluminum hydroxide and monophosphoryl lipid A) (Thoelen et al. 1998; Alderson et al. 2006), as well as virosomal formulations of antigens (Huckriede et al.”
A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
Coler, R. N., Baldwin, S. L., Shaverdian, N., Bertholet, S., Reed, S. J., Raman, V. S., Lu, X., DeVos, J., Hancock, K., Katz, J. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013677 · Cited by 149 · cited 4×
“2012) without causing adverse side effects (Coler et al. 2010).”
Self-citationPawelec, G. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(99)00010-x · Cited by 146 · cited 1×
“In mouse and man the activation of monocytes/macrophages as well as their capacity to present antigen and stimulate T cells seems to be impaired (McLachlan et al. 1995; Pawelec 1999; Castle 2000; Herrero et al. 2002; Plowden et al. 2004).”
Impact of aging on antigen presentation cell function of dendritic cells
Wong, C., & Goldstein, D. R. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.05.016 · Cited by 129 · cited 1×
“Age-related changes of DC are discussed controversially reporting increased, unchanged, or decreased function with age [reviewed in (Wong and Goldstein 2013)].”
Behzad, H., Huckriede, A. L. W., Haynes, L., Gentleman, B., Coyle, K., Wilschut, J. C., Kollmann, T. R., Reed, S. G., & McElhaney, J. E. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir769 · Cited by 128 · cited 3×
“It has recently been shown that GLA enhances T cell responses to influenza vaccine in old adults (Behzad et al. 2012).”
Self-citationThe frail elderly: role of dendritic cells in the susceptibility of infection
Uyemura, K., Castle, S. C., & Makinodan, T. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00033-7 · Cited by 127 · cited 1×
“In addition, the health status of the blood donors might greatly influence the outcome (Castle et al. 1999; Uyemura et al. 2002).”
Synthetic Toll-Like Receptor 4 Agonists Stimulate Innate Resistance to Infectious Challenge
Cluff, C. W., Baldridge, J. R., Stöver, A. G., Evans, J. T., Johnson, D. A., Lacy, M. J., Clawson, V. G., Yorgensen, V. M., Johnson, C. L., Livesay, M. T., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.3044-3052.2005 · Cited by 109 · cited 1×
“The licensed adjuvant AS04 contains monophosphoryl lipid A (MPL), which is derived from LPS but shows markedly reduced endotoxicity (Cluff et al. 2005).”
Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations
Anderson, R. C., Fox, C. B., Dutill, T. S., Shaverdian, N., Evers, T., Poshusta, G. R., Chesko, J., Coler, R. N., Friede, M., Reed, S. G., et al. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.08.022 · Cited by 105 · cited 1×
“Stimulation with GLA GLA (molecular weight 1763.5) was prepared as aqueous suspension as previously described (Anderson et al. 2010). moDC or PBMC were seeded in 24-well plates at a density of 0.5 9 106 moDC/well or in six-well plates at a density of 4 9 106 PBMC/well, respectively.”
Self-citationArias, M. A., Roey, G. A. V., Tregoning, J. S., Moutaftsi, M., Coler, R. N., Windish, H. P., Reed, S. G., Carter, D., & Shattock, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041144 · Cited by 101 · cited 3×
“The current study focused on the TLR4-mediated adjuvant candidate GLA, which has been shown to enhance the immunogenicity of co-administered antigens in mice and non-human primates (Coler et al. 2010, 2011; Arias et al. 2012) without causing adverse side effects (Coler et al.”
Self-citationAntitumoral properties of aged human monocytes.
McLachlan, J. A., Serkin, C. D., Morrey, K. M., & Bakouche, O. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.2.832 · Cited by 96 · cited 1×
“In mouse and man the activation of monocytes/macrophages as well as their capacity to present antigen and stimulate T cells seems to be impaired (McLachlan et al. 1995; Pawelec 1999; Castle 2000; Herrero et al. 2002; Plowden et al. 2004).”
Pantel, A. R., Cheong, C., Dandamudi, D. B., Shrestha, E., Mehandru, S., Brane, L., Ruane, D., Teixeira, A., Bozzacco, L., Steinman, R. M., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141855 · Cited by 87 · cited 2×
“Several studies have tested GLA as an adjuvant in human and murine vaccination and found GLA to be effective in inducing immunity to the adjuvanted antigen by stimulating DC (Coler et al. 2010, 2011; Arias et al. 2012; Pantel et al. 2012; Schneider et al. 2012).”
Pereira, L., de Souza, A. P. D., Borges, T. J., & Bonorino, C. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.03.005 · Cited by 86 · cited 2×
“2000) and of murine conventional DC stimulated with LPS (Pereira et al. 2011; Tan et al. 2012).”
TLR4 agonists as immunomodulatory agents
Alderson, M. R., McGowan, P., Baldridge, J. R., & Probst, P. (2006) · Journal of Endotoxin Research · doi:10.1177/09680519060120050701 · Cited by 80
Wong, C. P., Magnusson, K. R., & Ho, E. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.11.005 · Cited by 79 · cited 2×
“Previous reports demonstrated intact TLR4 expression in old age on human conventional DC and murine splenic DC (Jing et al. 2009; Wong et al. 2010), whereas macrophages of elderly mice were found to express lower levels of TLR4 and other TLRs on their surfaces than young mice (Renshaw et al. 2002).”
Masihi, K. N., Lange, W., Brehmer, W., & Ribi, E. E. (1986) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(86)90116-5 · Cited by 71 · cited 2×
“MPL has been shown to successfully enhance murine and human T cell responses against viruses and bacteria (Masihi et al. 1986; Persing et al. 2002) and to induce predominantly Th1 responses (Alderson et al. 2006).”
Ju, X., Clark, G., & Hart, D. N. J. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-421-0_1 · Cited by 63 · cited 1×
“TLRs recognize different ligands derived from bacteria, fungi, viruses or damaged host cells [reviewed in (Lee et al. 2012; Lim and Staudt 2013)].”
Ho, C. S. K., Munster, D. J., Pyke, C., Hart, D. N. J., & López, J. A. (2002) · Blood · doi:10.1182/blood.v99.8.2897 · Cited by 58 · cited 1×
“Unstimulated monocyte-derived and blood-derived DC have been shown to progressively up-regulate CD80 and CD86 in culture (Lung et al. 2000; Ho et al. 2002).”
Limited expansion of virus-specific CD8 T cells in the aged environment
Jiang, J., Bennett, A. J., Fisher, E., Williams-Bey, Y., Shen, H., & Murasko, D. M. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.08.007 · Cited by 55 · cited 2×
“2008) and the mode of cell preparation (Jiang et al. 2009).”
Saurwein-Teissl, M., Zisterer, K., Schmitt, T. L., Glück, R., Cryz, S. J., & Grubeck‐Loebenstein, B. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00714.x · Cited by 50 · cited 1×
“Our data are in concordance with previous findings showing intact responses of moDC from old donors to different stimuli (Saurwein-Teissl et al. 1998, 2000; Lung et al. 2000) and of murine conventional DC stimulated with LPS (Pereira et al. 2011; Tan et al. 2012).”
Self-citationAntigen presenting cell function is enhanced in healthy elderly
Castle, S. C., Uyemura, K., Crawford, W., Wong, W. B., & Makinodan, T. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00141-9 · Cited by 50 · cited 1×
“In addition, the health status of the blood donors might greatly influence the outcome (Castle et al. 1999; Uyemura et al. 2002).”
Lim, W., Ma, W., Gee, K., Aucoin, S., Nandan, D., Díaz‐Mitoma, F., Kozlowski, M., & Kumar, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1759 · Cited by 46 · cited 2×
“(Lim et al. 2002) found a down-regulation of CD86 on human monocytes after LPS stimulation in vitro, CD86 expression on monocytes from young and elderly donors was not affected by TLR4 stimulation in this study (Fig.”
Schneider, L. P., Schoonderwoerd, A., Moutaftsi, M., Howard, R. F., Reed, S. G., de Jong, E. C., & Teunissen, M. B. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.051 · Cited by 45 · cited 2×
“Several studies have tested GLA as an adjuvant in human and murine vaccination and found GLA to be effective in inducing immunity to the adjuvanted antigen by stimulating DC (Coler et al. 2010, 2011; Arias et al. 2012; Pantel et al. 2012; Schneider et al. 2012).”
Self-citationMonovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine
Walker, W. T., & Faust, S. N. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.141 · Cited by 40 · cited 2×
“other adjuvants such as AS03 (oil-in water emulsion containing squalene, Tween80 and a-tocopherol) (Walker and Faust 2010), AS04 (aluminum hydroxide and monophosphoryl lipid A) (Thoelen et al.”
Dendritic cells in old age-neglected by gerontology?
Saurwein-Teissl, M., Romani, N., & Grubeck-Loebenstein, B. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00203-7 · Cited by 32 · cited 1×
“Our data are in concordance with previous findings showing intact responses of moDC from old donors to different stimuli (Saurwein-Teissl et al. 1998, 2000; Lung et al. 2000) and of murine conventional DC stimulated with LPS (Pereira et al. 2011; Tan et al. 2012).”
Self-citationPhenotype and functions of conventional dendritic cells are not compromised in aged mice
Tan, S., Cavanagh, L. L., d'Advigor, W., Shackel, N., de St Groth, B. F., & Weninger, W. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.104 · Cited by 32 · cited 2×
“Statistical analysis Statistical analysis of the data was performed using SPSS version 11 (SPSS Inc., Chicago, US).”
Radford, K. J., Turtle, C. J., Kassianos, A. J., & Hart, D. N. J. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211310.90621.5d · Cited by 22 · cited 2×
“, blood-derived versus moDC (Osugi et al. 2002; Radford et al. 2006; Robbins et al. 2008) and the mode of cell preparation (Jiang et al.”
Cited by
Aging of the immune system: Focus on inflammation and vaccination
Pinti, M., Appay, V., Campisi, J., Frasca, D., Fülöp, T., Sauce, D., Larbi, A., Weinberger, B., & Cossarizza, A. (2016) · European Journal of Immunology · doi:10.1002/eji.201546178 · Cited by 439
Self-citationTargeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly
Pereira, B., Xu, X.-N., & Akbar, A. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583019 · Cited by 178
“The stimulatory effect of GLA-SE is well preserved in older adults (143) and in vitro studies in the context of vaccination with a split-virus influenza vaccine in older adults confirmed the activation of DCs to induce a Th1 response, increasing the interferon-g to IL-10 ratio and the cytolytic (granzyme B) response t…”
BackgroundThe complexities and challenges of preventing and treating nontuberculous mycobacterial diseases
Baldwin, S. L., Larsen, S. E., Ordway, D., Cassell, G., & Coler, R. N. (2019) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0007083 · Cited by 159
Self-citationCrooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110632 · Cited by 156
Adjuvant strategies to improve vaccination of the elderly population
Weinberger, B. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.03.014 · Cited by 87
Self-citation
Metadata
- Authors
- Weinberger, B., Joos, C., Reed, S. G., Coler, R., & Grubeck-Loebenstein, B.
- Affiliations
- Universität Innsbruck (AT)
- Infectious Disease Research Institute (US)
- Venue
- Biogerontology
- Published
- 2015-05-09
- Volume
- 17
- Issue
- 1
- Pages
- 177-187
- ISSN
- 1389-5729 (ISSN-L)
- 1573-6768
- OpenAlex
- W259039846
- Cited by
- 19
- References
- 47
- Citations by year
- 2025: 1 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 5 · 2017: 1 · 2016: 4
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Biogerontology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Seventh Framework Programme (280873 ADITEC)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- TLR4 agonist, vaccine adjuvants, aging, dendritic cells, monocytes, costimulatory molecules, cytokine production, IL-12, interleukin-6, TNF-α, IL-10, influenza vaccination, antigen-presenting cells
- MeSH terms
- Adjuvants, Immunologic, Adult, Aged, Aged, 80 and over, Aging, Antigen-Presenting Cells, Cells, Cultured, Female, Glucosides, Humans, Lipid A, Male, Middle Aged, Cytokines, Treatment Outcome, Vaccines, Subunit, Toll-Like Receptor 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.